Back to top
more

National Health Investors (NHI)

(Delayed Data from NYSE)

$76.45 USD

76.45
262,171

-0.20 (-0.26%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $76.46 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (66 out of 250)

Industry: REIT and Equity Trust - Other

Better trading starts here.

Zacks News

Employers Holdings (EIG) Beats Q3 Earnings Estimates

Employers Holdings (EIG) delivered earnings and revenue surprises of 3.85% and 0.53%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Park Hotels & Resorts (PK) Matches Q3 FFO Estimates

Park Hotels & Resorts (PK) delivered FFO and revenue surprises of 0% and 0.91%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

PLYM or NHI: Which Is the Better Value Stock Right Now?

PLYM vs. NHI: Which Stock Is the Better Value Option?

Cousins Properties (CUZ) Q3 FFO Meet Estimates

Cousins Properties (CUZ) delivered FFO and revenue surprises of 0% and 2.96%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's Why National Health Investors (NHI) is Poised for a Turnaround After Losing -10.18% in 4 Weeks

The heavy selling pressure might have exhausted for National Health Investors (NHI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PLYM vs. NHI: Which Stock Is the Better Value Option?

PLYM vs. NHI: Which Stock Is the Better Value Option?

Here's Why Welltower Stock is an Apt Portfolio Pick for Now

A rise in healthcare spending by senior citizens, capital-recycling efforts and a healthy balance sheet are likely to support WELL.

Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

ESRT vs. NHI: Which Stock Is the Better Value Option?

ESRT vs. NHI: Which Stock Is the Better Value Option?

Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?

Smart Beta ETF report for DIV

Is it a Wise Decision to Hold Healthpeak Properties Stock Now?

DOC is well-poised to gain from high demand for lab assets and rising senior citizens' healthcare spending despite competitive and high interest rate environment.

ESRT vs. NHI: Which Stock Should Value Investors Buy Now?

ESRT vs. NHI: Which Stock Is the Better Value Option?

National Health Investors (NHI) is a Great Momentum Stock: Should You Buy?

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

National Health Investors (NHI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for National Health Investors (NHI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

National Health Investors (NHI) Q2 FFO and Revenues Beat Estimates

National Health Investors (NHI) delivered FFO and revenue surprises of 7.27% and 4.26%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Stag Industrial (STAG) Q2 FFO and Revenues Beat Estimates

Stag (STAG) delivered FFO and revenue surprises of 3.39% and 1.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

National Health Investors (NHI) Is Up 3.44% in One Week: What You Should Know

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Is It Wise to Hold Healthpeak Properties (DOC) Stock Now?

High demand for lab assets and rising senior citizens' healthcare spending benefit Healthpeak Properties (DOC). However, competition from peers and higher interest rates are concerns.

Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?

Smart Beta ETF report for DIV

Are You Looking for a Top Momentum Pick? Why National Health Investors (NHI) is a Great Choice

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

National Health Investors (NHI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Strength Seen in Innovative Industrial Properties (IIPR): Can Its 4.8% Jump Turn into More Strength?

Innovative Industrial Properties (IIPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.

Industrial Logistics Properties Trust (ILPT) Tops Q1 FFO and Revenue Estimates

Industrial Logistics Properties Trust (ILPT) delivered FFO and revenue surprises of 7.69% and 1.54%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

National Health Investors (NHI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

National Health Investors (NHI) Q4 FFO Top Estimates

National Health Investors (NHI) delivered FFO and revenue surprises of 0.93% and 0.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?